Turn Organoid Drug Screening into Better Development Decisions

By integrating a patient-derived tumor organoid biobank, robotics, live-cell imaging, and AI-driven image and data analysis, our platform delivers actionable phenotypic insights that improve translational relevance and help de-risk drug development.

Explore Our Assay Capabilities

What is DrugVision.AI

DrugVision.AI is a service platform from the University of Antwerp and Antwerp University Hospital that brings together an in-house patient-derived organoid biobank, advanced robotic screening, and proprietary image and data analysis to translate complex screening data into meaningful biological insights that accelerate translational drug discovery and precision medicine.

Patient-Derived Organoid Biobank

Our in-house biobank of patient-derived tumor organoids preserves the diversity and complexity of human tumors, creating a powerful foundation for translational research and precision medicine.

Learn More

Robotic Screening Platform

Our state-of-the-art robotic screening platform enables scalable, high-throughput testing of drugs and drug combinations in patient-derived tumor organoids with speed, consistency and precision.

Learn More

Advanced Image and Data Analysis

Our proprietary image and data analysis pipeline transforms complex phenotypic screening data into robust, biologically meaningful, and clinically relevant insights at scale.

Learn More

Why Our Platform

Better data. Better decisions. Better therapies.

Beyond Endpoint Viability

Unlike ATP-based assays, our imaging-based growth metrics reveal how cells respond, distinguishing cytostatic from cytotoxic effects over time at a single organoid level.

Find the Right Patient for a Drug

Patient-derived tumor organoids capture the molecular features of the original tumor, helping identify biomarkers of drug response and improve patient stratification.

Find the Best Drug Combinations

Discover the most effective drug combinations by distinguishing truly synergistic and cytotoxic interactions from cytostatic or merely additive effects through our unique metrics.